Literature DB >> 11180887

Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings.

E Sasatomi1, O Tokunaga, K Miyazaki.   

Abstract

Two distinct epithelial lesions (dysplasia and adenoma) and one high-risk condition (anomalous pancreatico-biliary ductal junction; APBDJ) are currently recognized as premalignant stages of gallbladder carcinogenesis. In addition to clinicopathologic observations, recent molecular genetic studies have provided further insight into the pathogenesis and biological behavior of these precursor lesions. In this review, we concentrate on describing the histopathologic and clinicopathologic background and recent molecular genetic findings for each of these putative precursor lesions.

Entities:  

Mesh:

Year:  2000        PMID: 11180887     DOI: 10.1007/s005340070004

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  23 in total

1.  Dysplasia in Gallbladder: What Should We Do?

Authors:  Rehan Rais; Iván González; Deyali Chatterjee
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

2.  Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.

Authors:  Mateja Legan; Bostjan Luzar; Vera Ferlan Marolt; Andrej Cor
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Incidental findings during routine pathological evaluation of gallbladder specimens: review of 1,747 elective laparoscopic cholecystectomy cases.

Authors:  F Basak; M Hasbahceci; T Canbak; A Sisik; A Acar; M Yucel; G Bas; O Alimoglu
Journal:  Ann R Coll Surg Engl       Date:  2016-02-29       Impact factor: 1.891

Review 4.  Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.

Authors:  Amit Nandan Dhar Dwivedi; Shivi Jain; Ruhi Dixit
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

5.  Expression of human telomerase catalytic protein in gallbladder carcinogenesis.

Authors:  B Luzar; M Poljak; A Cör; U Klopcic; V Ferlan-Marolt
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 6.  [Precursor lesions of pancreatobiliary cancer].

Authors:  B Sipos; T Henopp
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 7.  Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.

Authors:  Mateja Legan
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

Review 8.  Gallbladder cancer: Clinical and pathological approach.

Authors:  Keita Kai; Shinichi Aishima; Kohji Miyazaki
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

9.  Expression of homeodomain protein CDX2 in gallbladder carcinomas.

Authors:  Xiang-Song Wu; Yoshimitsu Akiyama; Toru Igari; Tohru Kawamura; Susumu Hiranuma; Toshikatsu Shibata; Kouji Tsuruta; Morio Koike; Shigeki Arii; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-11       Impact factor: 4.553

10.  Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.

Authors:  Chanjuan Shi; Arjun Chandrasekaran; Paul J Thuluvath; Collins Karikari; Pedram Argani; Michael Goggins; Anirban Maitra; James R Eshleman
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.